Cilostazol - Global Market Insights and Sales Trends 2024

Publisher Name :
Date: 25-Dec-2023
No. of pages: 118
Inquire Before Buying

The global Cilostazol market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cilostazol in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Cilostazol market. Injection Cilostazol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-dried Powder Cilostazol segment is estimated at % CAGR for the next seven-year period.

Asia Pacific shows high growth potential for Cilostazol market, driven by demand from China, the second largest economy with some signs of stabilising, the Cilostazol market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Cilostazol, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Cilostazol market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Cilostazol market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cilostazol sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Cilostazol covered in this report include Pfizer, Teva, Otsuka Pharmaceutical, Novartis, Mylan, Squibb, Sandoz, Hikma Pharmaceuticals and GSK, etc.

The global Cilostazol market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

- Pfizer

- Teva

- Otsuka Pharmaceutical

- Novartis

- Mylan

- Squibb

- Sandoz

- Hikma Pharmaceuticals

- GSK

- Mayne Pharma

- Bedford Laboratories

- Abbott

- Takeda

- Zhejiang Weikang Pharmaceutical

- Chongqing Pharscin pharmaceutical

- Chengdu Leer Pharmaceutical

- Yantai Yisheng Pharmaceutical

- Cadila Pharmaceuticals

Global Cilostazol market, By Region:

- North America (U.S., Canada, Mexico)

- Europe (Germany, France, UK, Italy, etc.)

- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

- South America (Brazil, etc.)

- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Cilostazol market, Segment by Type:

- Injection Cilostazol

- Freeze-dried Powder Cilostazol

- Oral Cilostazol

Global Cilostazol market, by Application

- Hospital

- Clinic

- Others

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter Two: Detailed analysis of Cilostazol manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Three: Sales, revenue of Cilostazol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter Twelve: Analysis of sales channel, distributors and customers.

Chapter Thirteen: Research Findings and Conclusion.

Cilostazol - Global Market Insights and Sales Trends 2024

Table of Contents
1 Cilostazol Market Overview
1.1 Cilostazol Product Overview
1.2 Cilostazol Market Segment by Type
1.2.1 Injection Cilostazol
1.2.2 Freeze-dried Powder Cilostazol
1.2.3 Oral Cilostazol
1.3 Global Cilostazol Market Size by Type
1.3.1 Global Cilostazol Market Size Overview by Type (2018-2029)
1.3.2 Global Cilostazol Historic Market Size Review by Type (2018-2023)
1.3.3 Global Cilostazol Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Cilostazol Sales Breakdown by Type (2018-2023)
1.4.2 Europe Cilostazol Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Cilostazol Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Cilostazol Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Cilostazol Sales Breakdown by Type (2018-2023)
2 Global Cilostazol Market Competition by Company
2.1 Global Top Players by Cilostazol Sales (2018-2023)
2.2 Global Top Players by Cilostazol Revenue (2018-2023)
2.3 Global Top Players by Cilostazol Price (2018-2023)
2.4 Global Top Manufacturers Cilostazol Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cilostazol Market Competitive Situation and Trends
2.5.1 Cilostazol Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Cilostazol Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cilostazol as of 2022)
2.7 Date of Key Manufacturers Enter into Cilostazol Market
2.8 Key Manufacturers Cilostazol Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Cilostazol Status and Outlook by Region
3.1 Global Cilostazol Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Cilostazol Historic Market Size by Region
3.2.1 Global Cilostazol Sales in Volume by Region (2018-2023)
3.2.2 Global Cilostazol Sales in Value by Region (2018-2023)
3.2.3 Global Cilostazol Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Cilostazol Forecasted Market Size by Region
3.3.1 Global Cilostazol Sales in Volume by Region (2024-2029)
3.3.2 Global Cilostazol Sales in Value by Region (2024-2029)
3.3.3 Global Cilostazol Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Cilostazol by Application
4.1 Cilostazol Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Cilostazol Market Size by Application
4.2.1 Global Cilostazol Market Size Overview by Application (2018-2029)
4.2.2 Global Cilostazol Historic Market Size Review by Application (2018-2023)
4.2.3 Global Cilostazol Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Cilostazol Sales Breakdown by Application (2018-2023)
4.3.2 Europe Cilostazol Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Cilostazol Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Cilostazol Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Cilostazol Sales Breakdown by Application (2018-2023)
5 North America Cilostazol by Country
5.1 North America Cilostazol Historic Market Size by Country
5.1.1 North America Cilostazol Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Cilostazol Sales in Volume by Country (2018-2023)
5.1.3 North America Cilostazol Sales in Value by Country (2018-2023)
5.2 North America Cilostazol Forecasted Market Size by Country
5.2.1 North America Cilostazol Sales in Volume by Country (2024-2029)
5.2.2 North America Cilostazol Sales in Value by Country (2024-2029)
6 Europe Cilostazol by Country
6.1 Europe Cilostazol Historic Market Size by Country
6.1.1 Europe Cilostazol Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Cilostazol Sales in Volume by Country (2018-2023)
6.1.3 Europe Cilostazol Sales in Value by Country (2018-2023)
6.2 Europe Cilostazol Forecasted Market Size by Country
6.2.1 Europe Cilostazol Sales in Volume by Country (2024-2029)
6.2.2 Europe Cilostazol Sales in Value by Country (2024-2029)
7 Asia-Pacific Cilostazol by Region
7.1 Asia-Pacific Cilostazol Historic Market Size by Region
7.1.1 Asia-Pacific Cilostazol Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Cilostazol Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Cilostazol Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Cilostazol Forecasted Market Size by Region
7.2.1 Asia-Pacific Cilostazol Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Cilostazol Sales in Value by Region (2024-2029)
8 Latin America Cilostazol by Country
8.1 Latin America Cilostazol Historic Market Size by Country
8.1.1 Latin America Cilostazol Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Cilostazol Sales in Volume by Country (2018-2023)
8.1.3 Latin America Cilostazol Sales in Value by Country (2018-2023)
8.2 Latin America Cilostazol Forecasted Market Size by Country
8.2.1 Latin America Cilostazol Sales in Volume by Country (2024-2029)
8.2.2 Latin America Cilostazol Sales in Value by Country (2024-2029)
9 Middle East and Africa Cilostazol by Country
9.1 Middle East and Africa Cilostazol Historic Market Size by Country
9.1.1 Middle East and Africa Cilostazol Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Cilostazol Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Cilostazol Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Cilostazol Forecasted Market Size by Country
9.2.1 Middle East and Africa Cilostazol Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Cilostazol Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Cilostazol Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Cilostazol Products Offered
10.1.5 Pfizer Recent Development
10.2 Teva
10.2.1 Teva Company Information
10.2.2 Teva Introduction and Business Overview
10.2.3 Teva Cilostazol Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Teva Cilostazol Products Offered
10.2.5 Teva Recent Development
10.3 Otsuka Pharmaceutical
10.3.1 Otsuka Pharmaceutical Company Information
10.3.2 Otsuka Pharmaceutical Introduction and Business Overview
10.3.3 Otsuka Pharmaceutical Cilostazol Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Otsuka Pharmaceutical Cilostazol Products Offered
10.3.5 Otsuka Pharmaceutical Recent Development
10.4 Novartis
10.4.1 Novartis Company Information
10.4.2 Novartis Introduction and Business Overview
10.4.3 Novartis Cilostazol Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Novartis Cilostazol Products Offered
10.4.5 Novartis Recent Development
10.5 Mylan
10.5.1 Mylan Company Information
10.5.2 Mylan Introduction and Business Overview
10.5.3 Mylan Cilostazol Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Mylan Cilostazol Products Offered
10.5.5 Mylan Recent Development
10.6 Squibb
10.6.1 Squibb Company Information
10.6.2 Squibb Introduction and Business Overview
10.6.3 Squibb Cilostazol Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Squibb Cilostazol Products Offered
10.6.5 Squibb Recent Development
10.7 Sandoz
10.7.1 Sandoz Company Information
10.7.2 Sandoz Introduction and Business Overview
10.7.3 Sandoz Cilostazol Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Sandoz Cilostazol Products Offered
10.7.5 Sandoz Recent Development
10.8 Hikma Pharmaceuticals
10.8.1 Hikma Pharmaceuticals Company Information
10.8.2 Hikma Pharmaceuticals Introduction and Business Overview
10.8.3 Hikma Pharmaceuticals Cilostazol Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Hikma Pharmaceuticals Cilostazol Products Offered
10.8.5 Hikma Pharmaceuticals Recent Development
10.9 GSK
10.9.1 GSK Company Information
10.9.2 GSK Introduction and Business Overview
10.9.3 GSK Cilostazol Sales, Revenue and Gross Margin (2018-2023)
10.9.4 GSK Cilostazol Products Offered
10.9.5 GSK Recent Development
10.10 Mayne Pharma
10.10.1 Mayne Pharma Company Information
10.10.2 Mayne Pharma Introduction and Business Overview
10.10.3 Mayne Pharma Cilostazol Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Mayne Pharma Cilostazol Products Offered
10.10.5 Mayne Pharma Recent Development
10.11 Bedford Laboratories
10.11.1 Bedford Laboratories Company Information
10.11.2 Bedford Laboratories Introduction and Business Overview
10.11.3 Bedford Laboratories Cilostazol Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Bedford Laboratories Cilostazol Products Offered
10.11.5 Bedford Laboratories Recent Development
10.12 Abbott
10.12.1 Abbott Company Information
10.12.2 Abbott Introduction and Business Overview
10.12.3 Abbott Cilostazol Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Abbott Cilostazol Products Offered
10.12.5 Abbott Recent Development
10.13 Takeda
10.13.1 Takeda Company Information
10.13.2 Takeda Introduction and Business Overview
10.13.3 Takeda Cilostazol Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Takeda Cilostazol Products Offered
10.13.5 Takeda Recent Development
10.14 Zhejiang Weikang Pharmaceutical
10.14.1 Zhejiang Weikang Pharmaceutical Company Information
10.14.2 Zhejiang Weikang Pharmaceutical Introduction and Business Overview
10.14.3 Zhejiang Weikang Pharmaceutical Cilostazol Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Zhejiang Weikang Pharmaceutical Cilostazol Products Offered
10.14.5 Zhejiang Weikang Pharmaceutical Recent Development
10.15 Chongqing Pharscin pharmaceutical
10.15.1 Chongqing Pharscin pharmaceutical Company Information
10.15.2 Chongqing Pharscin pharmaceutical Introduction and Business Overview
10.15.3 Chongqing Pharscin pharmaceutical Cilostazol Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Chongqing Pharscin pharmaceutical Cilostazol Products Offered
10.15.5 Chongqing Pharscin pharmaceutical Recent Development
10.16 Chengdu Leer Pharmaceutical
10.16.1 Chengdu Leer Pharmaceutical Company Information
10.16.2 Chengdu Leer Pharmaceutical Introduction and Business Overview
10.16.3 Chengdu Leer Pharmaceutical Cilostazol Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Chengdu Leer Pharmaceutical Cilostazol Products Offered
10.16.5 Chengdu Leer Pharmaceutical Recent Development
10.17 Yantai Yisheng Pharmaceutical
10.17.1 Yantai Yisheng Pharmaceutical Company Information
10.17.2 Yantai Yisheng Pharmaceutical Introduction and Business Overview
10.17.3 Yantai Yisheng Pharmaceutical Cilostazol Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Yantai Yisheng Pharmaceutical Cilostazol Products Offered
10.17.5 Yantai Yisheng Pharmaceutical Recent Development
10.18 Cadila Pharmaceuticals
10.18.1 Cadila Pharmaceuticals Company Information
10.18.2 Cadila Pharmaceuticals Introduction and Business Overview
10.18.3 Cadila Pharmaceuticals Cilostazol Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Cadila Pharmaceuticals Cilostazol Products Offered
10.18.5 Cadila Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Cilostazol Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Cilostazol Industrial Chain Analysis
11.4 Cilostazol Market Dynamics
11.4.1 Cilostazol Industry Trends
11.4.2 Cilostazol Market Drivers
11.4.3 Cilostazol Market Challenges
11.4.4 Cilostazol Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Cilostazol Distributors
12.3 Cilostazol Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Major Company of Injection Cilostazol
Table 2. Major Company of Freeze-dried Powder Cilostazol
Table 3. Major Company of Oral Cilostazol
Table 4. Global Cilostazol Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Cilostazol Sales by Type (2018-2023) & (K Pcs)
Table 6. Global Cilostazol Sales Market Share in Volume by Type (2018-2023)
Table 7. Global Cilostazol Sales by Type (2018-2023) & (US& Million)
Table 8. Global Cilostazol Market Share in Value by Type (2018-2023)
Table 9. Global Cilostazol Price by Type (2018-2023) & (USD/Pcs)
Table 10. Global Cilostazol Sales by Type (2024-2029) & (K Pcs)
Table 11. Global Cilostazol Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Cilostazol Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Cilostazol Sales Market Share in Value by Type (2024-2029)
Table 14. Global Cilostazol Price by Type (2024-2029) & (USD/Pcs)
Table 15. North America Cilostazol Sales by Type (2018-2023) & (K Pcs)
Table 16. North America Cilostazol Sales by Type (2018-2023) & (US$ Million)
Table 17. Europe Cilostazol Sales (K Pcs) by Type (2018-2023)
Table 18. Europe Cilostazol Sales by Type (2018-2023) & (US$ Million)
Table 19. Asia-Pacific Cilostazol Sales (K Pcs) by Type (2018-2023)
Table 20. Asia-Pacific Cilostazol Sales by Type (2018-2023) & (US$ Million)
Table 21. Latin America Cilostazol Sales (K Pcs) by Type (2018-2023)
Table 22. Latin America Cilostazol Sales by Type (2018-2023) & (US$ Million)
Table 23. Middle East and Africa Cilostazol Sales (K Pcs) by Type (2018-2023)
Table 24. Middle East and Africa Cilostazol Sales by Type (2018-2023) & (US$ Million)
Table 25. Global Cilostazol Sales by Company (2018-2023) & (K Pcs)
Table 26. Global Cilostazol Sales Share by Company (2018-2023)
Table 27. Global Cilostazol Revenue by Company (2018-2023) & (US$ Million)
Table 28. Global Cilostazol Revenue Share by Company (2018-2023)
Table 29. Global Market Cilostazol Price by Company (2018-2023) & (USD/Pcs)
Table 30. Global Cilostazol Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Cilostazol Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cilostazol as of 2022)
Table 33. Date of Key Manufacturers Enter into Cilostazol Market
Table 34. Key Manufacturers Cilostazol Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Cilostazol Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Cilostazol Sales by Region (2018-2023) & (K Pcs)
Table 38. Global Cilostazol Sales Market Share in Volume by Region (2018-2023)
Table 39. Global Cilostazol Sales by Region (2018-2023) & (US$ Million)
Table 40. Global Cilostazol Sales Market Share in Value by Region (2018-2023)
Table 41. Global Cilostazol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 42. Global Cilostazol Sales by Region (2024-2029) & (K Pcs)
Table 43. Global Cilostazol Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Cilostazol Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Cilostazol Sales Market Share in Value by Region (2024-2029)
Table 46. Global Cilostazol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2029)
Table 47. Global Cilostazol Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Cilostazol Sales by Application (2018-2023) & (K Pcs)
Table 49. Global Cilostazol Sales Market Share in Volume by Application (2018-2023)
Table 50. Global Cilostazol Sales by Application (2018-2023) & (US$ Million)
Table 51. Global Cilostazol Sales Market Share in Value by Application (2018-2023)
Table 52. Global Cilostazol Price by Application (2018-2023) & (USD/Pcs)
Table 53. Global Cilostazol Sales by Application (2024-2029) & (K Pcs)
Table 54. Global Cilostazol Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Cilostazol Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Cilostazol Sales Market Share in Value by Application (2024-2029)
Table 57. Global Cilostazol Price by Application (2024-2029) & (USD/Pcs)
Table 58. North America Cilostazol Sales by Application (2018-2023) (K Pcs)
Table 59. North America Cilostazol Sales by Application (2018-2023) & (US$ Million)
Table 60. Europe Cilostazol Sales by Application (2018-2023) (K Pcs)
Table 61. Europe Cilostazol Sales by Application (2018-2023) & (US$ Million)
Table 62. Asia-Pacific Cilostazol Sales by Application (2018-2023) (K Pcs)
Table 63. Asia-Pacific Cilostazol Sales by Application (2018-2023) & (US$ Million)
Table 64. Latin America Cilostazol Sales by Application (2018-2023) (K Pcs)
Table 65. Latin America Cilostazol Sales by Application (2018-2023) & (US$ Million)
Table 66. Middle East and Africa Cilostazol Sales by Application (2018-2023) (K Pcs)
Table 67. Middle East and Africa Cilostazol Sales by Application (2018-2023) & (US$ Million)
Table 68. North America Cilostazol Sales by Country (2018-2023) & (K Pcs)
Table 69. North America Cilostazol Sales Market Share in Volume by Country (2018-2023)
Table 70. North America Cilostazol Sales by Country (2018-2023) & (US$ Million)
Table 71. North America Cilostazol Sales Market Share in Value by Country (2018-2023)
Table 72. North America Cilostazol Sales by Country (2024-2029) & (K Pcs)
Table 73. North America Cilostazol Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Cilostazol Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Cilostazol Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Cilostazol Sales by Country (2018-2023) & (K Pcs)
Table 77. Europe Cilostazol Sales Market Share in Volume by Country (2018-2023)
Table 78. Europe Cilostazol Sales by Country (2018-2023) & (US$ Million)
Table 79. Europe Cilostazol Sales Market Share in Value by Country (2018-2023)
Table 80. Europe Cilostazol Sales by Country (2024-2029) & (K Pcs)
Table 81. Europe Cilostazol Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Cilostazol Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Cilostazol Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Cilostazol Sales by Region (2018-2023) & (K Pcs)
Table 85. Asia-Pacific Cilostazol Sales Market Share in Volume by Region (2018-2023)
Table 86. Asia-Pacific Cilostazol Sales by Region (2018-2023) & (US$ Million)
Table 87. Asia-Pacific Cilostazol Sales Market Share in Value by Region (2018-2023)
Table 88. Asia-Pacific Cilostazol Sales by Region (2024-2029) & (K Pcs)
Table 89. Asia-Pacific Cilostazol Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Cilostazol Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Cilostazol Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Cilostazol Sales by Country (2018-2023) & (K Pcs)
Table 93. Latin America Cilostazol Sales Market Share in Volume by Country (2018-2023)
Table 94. Latin America Cilostazol Sales by Country (2018-2023) & (US$ Million)
Table 95. Latin America Cilostazol Sales Market Share in Value by Country (2018-2023)
Table 96. Latin America Cilostazol Sales by Country (2024-2029) & (K Pcs)
Table 97. Latin America Cilostazol Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Cilostazol Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Cilostazol Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Cilostazol Sales by Country (2018-2023) & (K Pcs)
Table 101. Middle East and Africa Cilostazol Sales Market Share in Volume by Country (2018-2023)
Table 102. Middle East and Africa Cilostazol Sales by Country (2018-2023) & (US$ Million)
Table 103. Middle East and Africa Cilostazol Sales Market Share in Value by Country (2018-2023)
Table 104. Middle East and Africa Cilostazol Sales by Country (2024-2029) & (K Pcs)
Table 105. Middle East and Africa Cilostazol Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Cilostazol Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Cilostazol Sales Market Share in Value by Country (2024-2029)
Table 108. Pfizer Company Information
Table 109. Pfizer Introduction and Business Overview
Table 110. Pfizer Cilostazol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 111. Pfizer Cilostazol Product
Table 112. Pfizer Recent Development
Table 113. Teva Company Information
Table 114. Teva Introduction and Business Overview
Table 115. Teva Cilostazol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 116. Teva Cilostazol Product
Table 117. Teva Recent Development
Table 118. Otsuka Pharmaceutical Company Information
Table 119. Otsuka Pharmaceutical Introduction and Business Overview
Table 120. Otsuka Pharmaceutical Cilostazol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 121. Otsuka Pharmaceutical Cilostazol Product
Table 122. Otsuka Pharmaceutical Recent Development
Table 123. Novartis Company Information
Table 124. Novartis Introduction and Business Overview
Table 125. Novartis Cilostazol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 126. Novartis Cilostazol Product
Table 127. Novartis Recent Development
Table 128. Mylan Company Information
Table 129. Mylan Introduction and Business Overview
Table 130. Mylan Cilostazol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 131. Mylan Cilostazol Product
Table 132. Mylan Recent Development
Table 133. Squibb Company Information
Table 134. Squibb Introduction and Business Overview
Table 135. Squibb Cilostazol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 136. Squibb Cilostazol Product
Table 137. Squibb Recent Development
Table 138. Sandoz Company Information
Table 139. Sandoz Introduction and Business Overview
Table 140. Sandoz Cilostazol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 141. Sandoz Cilostazol Product
Table 142. Sandoz Recent Development
Table 143. Hikma Pharmaceuticals Company Information
Table 144. Hikma Pharmaceuticals Introduction and Business Overview
Table 145. Hikma Pharmaceuticals Cilostazol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 146. Hikma Pharmaceuticals Cilostazol Product
Table 147. Hikma Pharmaceuticals Recent Development
Table 148. GSK Company Information
Table 149. GSK Introduction and Business Overview
Table 150. GSK Cilostazol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 151. GSK Cilostazol Product
Table 152. GSK Recent Development
Table 153. Mayne Pharma Company Information
Table 154. Mayne Pharma Introduction and Business Overview
Table 155. Mayne Pharma Cilostazol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 156. Mayne Pharma Cilostazol Product
Table 157. Mayne Pharma Recent Development
Table 158. Bedford Laboratories Company Information
Table 159. Bedford Laboratories Introduction and Business Overview
Table 160. Bedford Laboratories Cilostazol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 161. Bedford Laboratories Cilostazol Product
Table 162. Bedford Laboratories Recent Development
Table 163. Abbott Company Information
Table 164. Abbott Introduction and Business Overview
Table 165. Abbott Cilostazol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 166. Abbott Cilostazol Product
Table 167. Abbott Recent Development
Table 168. Takeda Company Information
Table 169. Takeda Introduction and Business Overview
Table 170. Takeda Cilostazol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 171. Takeda Cilostazol Product
Table 172. Takeda Recent Development
Table 173. Zhejiang Weikang Pharmaceutical Company Information
Table 174. Zhejiang Weikang Pharmaceutical Introduction and Business Overview
Table 175. Zhejiang Weikang Pharmaceutical Cilostazol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 176. Zhejiang Weikang Pharmaceutical Cilostazol Product
Table 177. Zhejiang Weikang Pharmaceutical Recent Development
Table 178. Chongqing Pharscin pharmaceutical Company Information
Table 179. Chongqing Pharscin pharmaceutical Introduction and Business Overview
Table 180. Chongqing Pharscin pharmaceutical Cilostazol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 181. Chongqing Pharscin pharmaceutical Cilostazol Product
Table 182. Chongqing Pharscin pharmaceutical Recent Development
Table 183. Chengdu Leer Pharmaceutical Company Information
Table 184. Chengdu Leer Pharmaceutical Introduction and Business Overview
Table 185. Chengdu Leer Pharmaceutical Cilostazol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 186. Chengdu Leer Pharmaceutical Cilostazol Product
Table 187. Chengdu Leer Pharmaceutical Recent Development
Table 188. Yantai Yisheng Pharmaceutical Company Information
Table 189. Yantai Yisheng Pharmaceutical Introduction and Business Overview
Table 190. Yantai Yisheng Pharmaceutical Cilostazol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 191. Yantai Yisheng Pharmaceutical Cilostazol Product
Table 192. Yantai Yisheng Pharmaceutical Recent Development
Table 193. Cadila Pharmaceuticals Company Information
Table 194. Cadila Pharmaceuticals Introduction and Business Overview
Table 195. Cadila Pharmaceuticals Cilostazol Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 196. Cadila Pharmaceuticals Cilostazol Product
Table 197. Cadila Pharmaceuticals Recent Development
Table 198. Key Raw Materials Lists
Table 199. Raw Materials Key Suppliers Lists
Table 200. Cilostazol Market Trends
Table 201. Cilostazol Market Drivers
Table 202. Cilostazol Market Challenges
Table 203. Cilostazol Market Restraints
Table 204. Cilostazol Distributors List
Table 205. Cilostazol Downstream Customers
Table 206. Research Programs/Design for This Report
Table 207. Key Data Information from Secondary Sources
Table 208. Key Data Information from Primary Sources
List of Figures
Figure 1. Cilostazol Product Picture
Figure 2. Global Cilostazol Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Cilostazol Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Cilostazol Sales Status and Outlook (2018-2029) & (K Pcs)
Figure 5. Product Picture of Injection Cilostazol
Figure 6. Global Injection Cilostazol Sales YoY Growth (2018-2029) & (K Pcs)
Figure 7. Product Picture of Freeze-dried Powder Cilostazol
Figure 8. Global Freeze-dried Powder Cilostazol Sales YoY Growth (2018-2029) & (K Pcs)
Figure 9. Product Picture of Oral Cilostazol
Figure 10. Global Oral Cilostazol Sales YoY Growth (2018-2029) & (K Pcs)
Figure 11. Global Cilostazol Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Cilostazol Sales Market Share by Type in 2022 & 2029
Figure 13. North America Cilostazol Sales Market Share in Volume by Type in 2022
Figure 14. North America Cilostazol Sales Market Share in Value by Type in 2022
Figure 15. Europe Cilostazol Sales Market Share in Volume by Type in 2022
Figure 16. Europe Cilostazol Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Cilostazol Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Cilostazol Sales Market Share in Value by Type in 2022
Figure 19. Latin America Cilostazol Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Cilostazol Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Cilostazol Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Cilostazol Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Cilostazol Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Cilostazol Revenue in 2022
Figure 25. Cilostazol Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Hospital
Figure 27. Global Hospital Sales YoY Growth (2018-2029) & (K Pcs)
Figure 28. Product Picture of Clinic
Figure 29. Global Clinic Sales YoY Growth (2018-2029) & (K Pcs)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2018-2029) & (K Pcs)
Figure 32. Global Cilostazol Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Cilostazol Sales Market Share by Application in 2022 & 2029
Figure 34. North America Cilostazol Sales Market Share in Volume by Application in 2022
Figure 35. North America Cilostazol Sales Market Share in Value by Application in 2022
Figure 36. Europe Cilostazol Sales Market Share in Volume by Application in 2022
Figure 37. Europe Cilostazol Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Cilostazol Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Cilostazol Sales Market Share in Value by Application in 2022
Figure 40. Latin America Cilostazol Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Cilostazol Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Cilostazol Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Cilostazol Manufacturing Cost Structure
Figure 45. Cilostazol Industrial Chain Analysis
  • Global Digoxin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 75
    According to our LPI (LP Information) latest study, the global Digoxin market size was valued at US$ 59 million in 2023. With growing demand in downstream market, the Digoxin is forecast to a readjusted size of US$ 73 million by 2030 with a CAGR of 3.2% during review period. The research report highlights the growth potential of the global Digoxin market. Digoxin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain op......
  • Global Heart Failure Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Heart Failure Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Heart Failure Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Heart Failure Drugs market. Heart Failure Drugs are expected to show stable growth in the future market. However, product differentiatio......
  • Global Atorvastatin Calcium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 138
    According to our LPI (LP Information) latest study, the global Atorvastatin Calcium market size was valued at US$ 214.2 million in 2023. With growing demand in downstream market, the Atorvastatin Calcium is forecast to a readjusted size of US$ 362 million by 2030 with a CAGR of 7.8% during review period. The research report highlights the growth potential of the global Atorvastatin Calcium market. Atorvastatin Calcium are expected to show stable growth in the future market. However, prod......
  • Global Rosuvastatin Calcium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 139
    According to our LPI (LP Information) latest study, the global Rosuvastatin Calcium market size was valued at US$ 514.3 million in 2023. With growing demand in downstream market, the Rosuvastatin Calcium is forecast to a readjusted size of US$ 683.6 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Rosuvastatin Calcium market. Rosuvastatin Calcium are expected to show stable growth in the future market. However, pr......
  • Global Atorvastatin Calcium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 133
    According to our (Global Info Research) latest study, the global Atorvastatin Calcium market size was valued at USD 225.3 million in 2023 and is forecast to a readjusted size of USD 366.1 million by 2030 with a CAGR of 7.2% during review period. Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL choleste......
  • Global Rosuvastatin Calcium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 132
    According to our (Global Info Research) latest study, the global Rosuvastatin Calcium market size was valued at USD 540.9 million in 2023 and is forecast to a readjusted size of USD 703.6 million by 2030 with a CAGR of 3.8% during review period. Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart att......
  • Cilostazol - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 118
    The global Cilostazol market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cilostazol in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Cilostazol market. Injection Cilostazol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-dried P......
  • Rosuvastatin - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 110
    Rosuvastatin medication is a statin that is used to lower bad cholesterol and prevent cardiovascular disease. It works by blocking an enzyme in the liver that makes cholesterol. It is taken by mouth and should be used together with dietary changes, exercise, and weight loss. It may also raise good cholesterol and lower triglycerides. It is sold under the brand name Crestor among others. It may be used when other statins have not worked well. The global Rosuvastatin market size is expected......
  • Global Congestive Heart Failure Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 19-Dec-2023        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Congestive Heart Failure Drugs market: According to our latest research, the global Congestive Heart Failure Drugs market looks promising in the next 5 years. As of 2022, the global Congestive Heart Failure Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Congestive heart failure is a serious and complex condition in which the heart muscles are either dam......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs